Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Swain

Showing results (41-50 of 601) with videos related to

Pageof 61
Sort By:
Journal of Cancer Research and Clinical Oncology|October 18, 2003
The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel reviewS M Swain, P Vici
Oncology (Williston Park, N.Y.)|May 27, 2014
Pertuzumab: increasing the optionsRaquel Nunes, Sandra M Swain
Cancers|March 29, 2023
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel TargetsNadia Ashai, Sandra M Swain
JAMA Oncology|June 30, 2016
Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?Ana Barac, Sandra M Swain
American Journal of Obstetrics and Gynecology|September 1, 1988
Systemic tocolysis for premature labor is associated with an increased incidence of pulmonary edema in the presence of maternal infectionC G Hatjis, M Swain
Cancer Investigation|June 13, 2014
Pertuzumab for the treatment of breast cancerFilipa Lynce, Sandra M Swain
JAMA|October 17, 2013
Drug discount programSandra M Swain, Jeffery C Ward
The Oncologist|March 18, 2016
Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?Michael S Ewer, Sandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Contralateral breast cancer: where does it all begin?Suparna Bonthala Wedam, Sandra M Swain
Seminars in Oncology|December 20, 2005
Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR)James J Lee, Sandra M Swain
Pageof 61

Showing results (41-50 of 601) with videos related to

Sort By:
Pageof 61
Journal of Cancer Research and Clinical Oncology|October 18, 2003
The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel reviewS M Swain, P Vici
Oncology (Williston Park, N.Y.)|May 27, 2014
Pertuzumab: increasing the optionsRaquel Nunes, Sandra M Swain
Cancers|March 29, 2023
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel TargetsNadia Ashai, Sandra M Swain
JAMA Oncology|June 30, 2016
Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?Ana Barac, Sandra M Swain
American Journal of Obstetrics and Gynecology|September 1, 1988
Systemic tocolysis for premature labor is associated with an increased incidence of pulmonary edema in the presence of maternal infectionC G Hatjis, M Swain
Cancer Investigation|June 13, 2014
Pertuzumab for the treatment of breast cancerFilipa Lynce, Sandra M Swain
JAMA|October 17, 2013
Drug discount programSandra M Swain, Jeffery C Ward
The Oncologist|March 18, 2016
Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?Michael S Ewer, Sandra M Swain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Contralateral breast cancer: where does it all begin?Suparna Bonthala Wedam, Sandra M Swain
Seminars in Oncology|December 20, 2005
Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR)James J Lee, Sandra M Swain
Pageof 61